Literature DB >> 30659436

Bioactive molecules from Nocardia: diversity, bioactivities and biosynthesis.

Dipesh Dhakal1, Vijay Rayamajhi1, Ravindra Mishra1, Jae Kyung Sohng2,3.   

Abstract

Nocardia spp. are catalase positive, aerobic, and non-motile Gram-positive filamentous bacteria. Many Nocarida spp. have been reported as unusual causes of diverse clinical diseases in both humans and animals. Therefore, they have been studied for a long time, primarily focusing on strain characterization, taxonomic classification of new isolates, and host pathophysiology. Currently, there are emerging interests in isolating bioactive molecules from diverse actinobacteria including Nocardia spp. and studying their biosynthetic mechanisms. In addition, these species possess significant metabolic capacity, which has been utilized for generating diverse functionalized bioactive molecules by whole cell biotransformation. This review summarizes the structural diversity and biological activities of compounds biosynthesized or biotransformed by Nocardia spp. Furthermore, the recent advances on biosynthetic mechanisms and genetic engineering approaches for enhanced production or structural/functional modification are presented.

Entities:  

Keywords:  Bioactive compounds; Biosynthetic mechanism; Biotransformation; Nocardia spp.; Structural modifications

Mesh:

Substances:

Year:  2019        PMID: 30659436     DOI: 10.1007/s10295-018-02120-y

Source DB:  PubMed          Journal:  J Ind Microbiol Biotechnol        ISSN: 1367-5435            Impact factor:   3.346


  7 in total

1.  Targeted 16S rRNA gene and ITS2 amplicon sequencing of leaf and spike tissues of Piper longum identifies new candidates for bioprospecting of bioactive compounds.

Authors:  Sushma Mishra; Deepika Goyal; Laccy Phurailatpam
Journal:  Arch Microbiol       Date:  2021-05-19       Impact factor: 2.552

Review 2.  Recent Advances in Strategies for Activation and Discovery/Characterization of Cryptic Biosynthetic Gene Clusters in Streptomyces.

Authors:  Chung Thanh Nguyen; Dipesh Dhakal; Van Thuy Thi Pham; Hue Thi Nguyen; Jae-Kyung Sohng
Journal:  Microorganisms       Date:  2020-04-24

3.  Complete Genome Sequence of Nocardia sp. Strain CS682, a Producer of Antibacterial Compound Nargenicin A1.

Authors:  Dipesh Dhakal; Vijay Rayamajhi; Hue Thi Nguyen; Purna Bahadur Poudel; Jae Kyung Sohng
Journal:  Microbiol Resour Announc       Date:  2019-12-05

4.  iChip-Inspired Isolation, Bioactivities and Dereplication of Actinomycetota from Portuguese Beach Sediments.

Authors:  José Diogo Neves Dos Santos; Susana Afonso João; Jesús Martín; Francisca Vicente; Fernando Reyes; Olga Maria Lage
Journal:  Microorganisms       Date:  2022-07-20

5.  Nargenicin A1 attenuates lipopolysaccharide-induced inflammatory and oxidative response by blocking the NF-κB signaling pathway.

Authors:  Da Hye Kwon; Gi-Young Kim; Hee-Jae Cha; Suhkmann Kim; Heui-Soo Kim; Hye-Jin Hwang; Yung Hyun Choi
Journal:  EXCLI J       Date:  2021-05-28       Impact factor: 4.068

6.  New Nocobactin Derivatives with Antimuscarinic Activity, Terpenibactins A-C, Revealed by Genome Mining of Nocardia terpenica IFM 0406.

Authors:  Julia Chen; Andri Frediansyah; Daniel Männle; Jan Straetener; Heike Brötz-Oesterhelt; Nadine Ziemert; Leonard Kaysser; Harald Gross
Journal:  Chembiochem       Date:  2020-04-02       Impact factor: 3.164

7.  Genome insights into the pharmaceutical and plant growth promoting features of the novel species Nocardia alni sp. nov.

Authors:  Imen Nouioui; Sung-Min Ha; Inwoo Baek; Jongsik Chun; Michael Goodfellow
Journal:  BMC Genomics       Date:  2022-01-21       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.